Approving Drugs Based on Early Stage Data - How Phase II Trial Data Correlates with Phase III Outcomes. Case Study- NSCLC
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2160
https://www.valueinhealthjournal.com/article/S1098-3015(14)04090-X/fulltext
Title :
Approving Drugs Based on Early Stage Data - How Phase II Trial Data Correlates with Phase III Outcomes. Case Study- NSCLC
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04090-X&doi=10.1016/j.jval.2014.08.2160
First page :
A614
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1621